{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:32:07Z","timestamp":1698474727375},"reference-count":26,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.15-208","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T22:05:43Z","timestamp":1452031543000},"page":"53-60","source":"Crossref","is-referenced-by-count":6,"title":["Improvements in Augmentation Index and Urinary Albumin Excretion With Benidipine in Hypertensive Patients With Chronic Kidney Disease"],"prefix":"10.1536","volume":"57","author":[{"given":"Tadateru","family":"Takayama","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Yoda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Yajima","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kasamaki","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kunimoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.","DOI":"10.1056\/NEJMoa041031"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bouchi R, Babazono T, Yoshida N, <i>et al<\/i>. Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes. Hypertens Res 2010; 33: 1298-304.","DOI":"10.1038\/hr.2010.170"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ishisone T, Koeda Y, Tanaka F, Sato K, Nagano M, Nakamura M. Comparison of utility of arterial stiffness parameters for predicting cardiovascular events in the general population. Int Heart J 2013; 54: 160-5.","DOI":"10.1536\/ihj.54.160"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol 2002; 17: 543-51. (Review)","DOI":"10.1097\/00001573-200209000-00016"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shimamoto K, Ando K, Fujita T, <i>et al<\/i>. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253-392.","DOI":"10.1038\/hr.2014.20"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wheeler DC, Becker GJ. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 2013; 83: 377-83. (Review)","DOI":"10.1038\/ki.2012.425"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takenaka T, Takane H, Okada H, Ohno Y, Suzuki H. Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney diseases. NDT Plus 2009; 2: 192-3.","DOI":"10.1093\/ndtplus\/sfp014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Uzu T, Nishimura M, Fujii T, <i>et al<\/i>. Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome. Hypertens Res 2007; 30: 161-5.","DOI":"10.1291\/hypres.30.161"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miyagawa K, Dohi Y, Nakazawa A, <i>et al<\/i>. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine. Clin Exp Hypertens 2010; 32: 1-7.","DOI":"10.3109\/10641960902929446"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nishigaki K, Inoue Y, Yamanouchi Y, <i>et al<\/i>. Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis. Circ J 2010; 74: 1943-50.","DOI":"10.1253\/circj.CJ-10-0292"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miwa Y, Masai H, Shimizu M. Differential effects of calcium-channel blockers on vascular endothelial function in patients with coronary spastic angina. Circ J 2009; 73: 713-7.","DOI":"10.1253\/circj.CJ-08-0188"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Matsuo S, Imai E, Horio M, <i>et al<\/i>; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wheeler DC, Becker GJ. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 2013; 83: 377-83. (Review)","DOI":"10.1038\/ki.2012.425"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hayashi K, Homma K, Wakino S, <i>et al<\/i>. T-type Ca channel blockade as a determinant of kidney protection. Keio J Med 2010; 59: 84-95. (Review)","DOI":"10.2302\/kjm.59.84"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000; 525: 263-70.","DOI":"10.1111\/j.1469-7793.2000.t01-1-00263.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wilkinson IB, Mohammad NH, Tyrrell S, <i>et al<\/i>. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002; 15: 24-30.","DOI":"10.1016\/S0895-7061(01)02252-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nakamura T, Sato E, Fujiwara N, <i>et al<\/i>. Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease. Am J Med Sci 2010; 339: 157-63.","DOI":"10.1097\/MAJ.0b013e3181c643df"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Abe M, Okada K, Maruyama N, <i>et al<\/i>. Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. Hypertens Res 2011; 34: 268-73.","DOI":"10.1038\/hr.2010.221"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res 2007; 100: 342-53. (Review)","DOI":"10.1161\/01.RES.0000256155.31133.49"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tani S, Takahashi A, Nagao K, Hirayama A. Effects of the T\/L-type calcium channel blocker benidipine on albuminuria and plasma aldosterone concentration. A pilot study involving switching from L-type calcium channel blockers to benidipine. Int Heart J 2014; 55: 519-25.","DOI":"10.1536\/ihj.14-034"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Morikawa T, Okumura M, Konishi Y, Okada N, Imanishi M. Effects of benidipine on glomerular hemodynamics and proteinuria in patients with nondiabetic nephropathy. Hyper-tens Res 2002; 25: 571-6.","DOI":"10.1291\/hypres.25.571"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Omae K, Ogawa T, Nitta K. Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease. Heart Vessels 2009; 24: 301-7.","DOI":"10.1007\/s00380-008-1125-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, <i>et al<\/i>. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-85.","DOI":"10.1056\/NEJMoa1001286"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fujita T, Ando K, Nishimura H, <i>et al<\/i>; Cilnidipine versus Amlodipine Randomised Trial for Evaluation in Renal Disease (CARTER) Study Investigators. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int 2007; 72: 1543-9.","DOI":"10.1038\/sj.ki.5002623"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yokoyama H, Sone H, Saito K, Yamada D, Honjo J, Haneda M. Flow-mediated dilation is associated with microalbuminuria independent of cardiovascular risk factors in type 2 diabetes \u2013 interrelations with arterial thickness and stiffness. J Atheroscler Thromb 2011; 18: 744-52.","DOI":"10.5551\/jat.7526"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dohi Y, Kojima M, Sato K. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension 1996; 28: 58-63.","DOI":"10.1161\/01.HYP.28.1.58"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/1\/57_15-208\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T06:04:37Z","timestamp":1567490677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/1\/57_15-208\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.15-208","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}